Vanda Pharmaceuticals
VNDA
#8239
Rank
NZ$0.53 B
Marketcap
NZ$8.95
Share price
-3.36%
Change (1 day)
13.61%
Change (1 year)

Earnings for Vanda Pharmaceuticals (VNDA)

Earnings in 2026 (TTM): -NZ$0.28 Billion

According to Vanda Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.21 Billion. In 2025 the company made an earning of -NZ$0.27 Billion a decrease over its 2024 earnings that were of -NZ$70.24 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Vanda Pharmaceuticals from 2005 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$0.28 Billion4.97%
2025 -NZ$0.27 Billion271.79%
2024 -NZ$70.24 Million191.43%
2023 -NZ$24.11 Million-320.45%
2022 NZ$10.93 M-84.99%
2021 NZ$72.83 M54.8%
2020 NZ$47.05 M19.42%
2019 NZ$39.4 M4.93%
2018 NZ$37.55 M-228.6%
2017 -NZ$29.2 Million-8.98%
2016 -NZ$32.08 Million-53.79%
2015 -NZ$69.42 Million-30.18%
2014 -NZ$99.43 Million173.08%
2013 -NZ$36.41 Million-25.33%
2012 -NZ$48.76 Million163.61%
2011 -NZ$18.5 Million-221.15%
2010 NZ$15.26 M-124.53%
2009 -NZ$62.25 Million-29.44%
2008 -NZ$88.21 Million-36.2%
2007 -NZ$0.14 Billion21.81%
2006 -NZ$0.12 Billion170.55%
2005 -NZ$41.96 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$44.87 B-16,300.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$27.26 B-9,942.61%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$18.29 B-6,704.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$53.76 B-19,508.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$22.71 B-8,301.34%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$16.57 B-6,084.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Titan Pharmaceuticals
TTNP
-NZ$4.85 Million-98.25%๐Ÿ‡บ๐Ÿ‡ธ USA